HTG MOLECULAR DIAGNOSTICS (HTGM) Stock Analyst Earnings Estimates
NASDAQ:HTGM - Nasdaq - US40434H3021 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.55M -55.47% | 8.907M 4.17% | 6.366M -28.52% | 6.528M 2.54% | 15.3M 134.38% | |
| EBITDA YoY % growth | -18.24M -3.05% | -17.103M 6.24% | -20.242M -18.36% | N/A | N/A | |
| EBIT YoY % growth | -19.59M -3.32% | -17.824M 9.02% | -20.83M -16.86% | -15.616M 25.03% | -22.44M -43.70% | |
| Operating Margin | -229.12% | -200.11% | -327.19% | -239.22% | -146.67% | |
| EPS YoY % growth | -52.56 43.85% | -32.88 37.44% | -25.59 22.16% | -4.72 81.55% | -1.08 77.11% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -1.88 71.04% | -1.03 79.06% | -0.67 84.95% |
| Revenue Q2Q % growth | 1.632M 9.41% | 1.632M 30.47% | 1.632M -33.10% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.968M 30.11% | -3.815M 12.26% | -3.662M 19.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -2.28 76.54% | -1.98 | -0.30 | -15.22% |
| Q4 2022 Q2Q % growth | -4.47 45.98% | -2.46 | -2.01 | -81.95% |
| Q3 2022 Q2Q % growth | -4.92 31.67% | -6.55 | 1.63 | 24.87% |
| Q2 2022 Q2Q % growth | -6.48 16.92% | -7.41 | 0.93 | 12.49% |
| Q1 2022 Q2Q % growth | -9.72 -1.25% | -8.75 | -0.97 | -11.07% |
| Q4 2021 Q2Q % growth | -8.28 25.81% | -7.18 | -1.10 | -15.31% |
| Q3 2021 Q2Q % growth | -7.20 42.86% | -8.14 | 0.94 | 11.54% |
| Q2 2021 Q2Q % growth | -7.80 45.83% | -9.39 | 1.59 | 16.97% |
| Q1 2021 Q2Q % growth | -9.60 33.33% | -12.48 | 2.88 | 23.11% |
| Q4 2020 Q2Q % growth | -11.16 -520.00% | -13.77 | 2.61 | 18.95% |
| Q3 2020 Q2Q % growth | -12.60 53.33% | -14.23 | 1.63 | 11.45% |
| Q2 2020 Q2Q % growth | -14.40 52.94% | -15.61 | 1.21 | 7.73% |
| Q1 2020 Q2Q % growth | -14.40 57.89% | -16.07 | 1.67 | 10.36% |
| Q4 2019 Q2Q % growth | -1.80 | -16.52 | 14.72 | 89.11% |
| Q3 2019 Q2Q % growth | -27.00 | -29.01 | 2.01 | 6.92% |
| Q2 2019 Q2Q % growth | -30.60 | -27.91 | -2.69 | -9.65% |
| Q1 2019 Q2Q % growth | -34.20 | -35.99 | 1.79 | 4.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 1.033M -12.83% | 1.632M | -599.49K | -36.73% |
| Q4 2022 Q2Q % growth | 2.439M -15.22% | 2.484M | -44.69K | -1.80% |
| Q3 2022 Q2Q % growth | 1.251M -50.37% | 2.907M | -1.656M | -56.97% |
| Q2 2022 Q2Q % growth | 1.492M -28.09% | 2.55M | -1.058M | -41.51% |
| Q1 2022 Q2Q % growth | 1.184M -17.75% | 2.193M | -1.009M | -45.99% |
| Q4 2021 Q2Q % growth | 2.877M 11.51% | 3.026M | -148.93K | -4.92% |
| Q3 2021 Q2Q % growth | 2.52M 41.60% | 2.703M | -182.59K | -6.76% |
| Q2 2021 Q2Q % growth | 2.074M 5.83% | 2.168M | -93.8K | -4.33% |
| Q1 2021 Q2Q % growth | 1.44M -35.43% | 1.729M | -289K | -16.71% |
| Q4 2020 Q2Q % growth | 2.58M -46.25% | 2.372M | 208K | 8.77% |
| Q3 2020 Q2Q % growth | 1.78M -67.04% | 2.273M | -493K | -21.69% |
| Q2 2020 Q2Q % growth | 1.96M -66.21% | 1.823M | 137K | 7.52% |
| Q1 2020 Q2Q % growth | 2.23M -30.31% | 2.871M | -641K | -22.33% |
| Q4 2019 Q2Q % growth | 4.8M | 4.947M | -147K | -2.97% |
| Q3 2019 Q2Q % growth | 5.4M | 5.58M | -180K | -3.23% |
| Q2 2019 Q2Q % growth | 5.8M | 5.667M | 133K | 2.35% |
| Q1 2019 Q2Q % growth | 3.2M | 2.781M | 419K | 15.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -162.86% | 0% | -67.75% |
| Revenue | 0% | -28.89% | 0% | -34.02% |